bioRxivBioinformaticsPreprint
Investigate Inhibitory Effects of Ginger polyphenols compare to Simvastatin towards HMG-CoA reductase: An Integrated Molecular Docking and Molecular dynamic simulation
Aweke Mulu BelachewiD, Asheber Feyisa, Mulugeta Gajaa Ufgaa, Teslim Yimama Yesuf
Abstract
Diabetes is an increasing problem in Ethiopia, affecting up to 6.5% of Ethiopian adults. There are serious complications associated with diabetes including macrovascular and microvascular. Controlling Lipid profiles and blood glucose significantly reduces the risk of complications. Statins are the only current treatment for both type 1 diabetes and Type 2 diabetes dyslipidemia. HMG-CoA reductase plays a central role in the production of cholesterol which, associated with cardiovascular disease (CVD). Statins have been found to reduce cardiovascular disease and mortality in those who are at high risk. Nonetheless, it has adverse effect, such as drug-related hypoglycemia and high cost. These situations lead to develop suitable phytotherapeutic agents with less frequent side effects. Ginger (Zingiber officinale) is widely consumed as a spice, and numerous studies suggest that ginger may have beneficial effects for diabetes and dyslipidemia. But, further studies are needed to investigate effects of binding affinity and binding site residues for major ginger extract polyphenols towards target HMG-CoA reductase. In this study, ADMET web server, Auto-Dock 5.4 and Gromacs 2020 were used. Out of eleven major gingers polyphenols screened three selected based on docking energy compare to Simvastatin for MD simulation. The predicted binding affinity for 6-paradol, 6-shogaol and gingerdione were -8.51, -6.93, -9.24 kcal/mol, respectively. The results of molecular dynamic simulation are consistence with docking. The predicted ligand binding site residues are Arg641, Gly808, Arg641, Met781, Ser794 and Arg595. In conclusion, 6-paradol, 6-shogaol and gingerdione could be possible therapy because, of interactions with target HMG-CoA reductase. Therefore, further wet lab study will be needed, for the better understanding of the mechanism of action of ginger extract by which it modulates liver and kidney vivo condition.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of Novel Inhibitors of HMG-CoA Reductase using Bioactive Compounds isolated from Cochlospermum Species through Computational Methods
Toba Isaac Olatoye·JMIRx BioPeer-reviewed·Jul 10, 2025
- Exploring repositioning opportunities and side-effects of statins: a Mendelian randomization study of HMG-CoA reductase inhibition with 55 complex traits
Hon‐Cheong So, Carlos Kwan‐Long Chau, Kai Zhao·bioRxiv·Dec 23, 2017
- Human genetics suggests differing causal pathways from HMGCR inhibition to coronary artery disease and type 2 diabetes
Seongwon Hwang, Ville Karhunen, … Stephen Burgess·International Journal of EpidemiologyPeer-reviewed·Dec 25, 2025
- TLR4 Modulates Simvastatin's Impact on HDL Cholesterol and Glycemic Control
Xiao Tian, Peixiang Zhang·Frontiers in PharmacologyPeer-reviewed·Jan 16, 2026
- In Silico Screening of Indian Medicinal Herb Compounds for Intestinal α-Glucosidase Inhibition with ADMET and Toxicity Assessment for Postprandial Glucose Management in Type-2 Diabetes
Ashim Chandra Roy, Ilora Ghosh·bioRxiv·Mar 3, 2026
- In vivo and in silico experiment on Mitragyna speciosa offers new insight of antidiabetic potentials
M. U. Hossain, M. S. Hossain, … M. Salimullah·bioRxiv·Nov 8, 2023